KalVista Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KALV and other ETFs, options, and stocks.About KALV
KalVista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. Its product candidates are inhibitors of plasma kallikrein being developed for two indications: Sebetralstat for HAE and Factor XIIa.
KALV Key Statistics
Stock Snapshot
The current KalVista Pharmaceuticals(KALV) stock price is $15.83, with a market capitalization of 799.64M. The stock trades at a price-to-earnings (P/E) ratio of -3.96.
During the trading session on 2026-02-22, KalVista Pharmaceuticals(KALV) shares reached a daily high of $16.11 and a low of $15.58. At a current price of $15.83, the stock is +1.6% higher than the low and still -1.7% under the high.
Trading volume for KalVista Pharmaceuticals(KALV) stock has reached 338.34K, versus its average volume of 652.89K.
The stock's 52-week range extends from a low of $9.24 to a high of $19.00.
The stock's 52-week range extends from a low of $9.24 to a high of $19.00.
Analyst ratings
100%
of 9 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.